retatrutide efficacy weight loss phase 2 trial results Looking forward to when # retatrutide's 3 will become available How Does Retatrutide Make You

Bills like the Treat and Reduce Obesity Ac t would allow Part D to cover FDA-approved weight-loss drugs more broadly, but as of late 2025, no such law has passed.

Meanwhile, the broader senolytic field has advanced dasatinib+quercetin has completed multiple human trials including Phase 2 in Nature Medicine (Farr 2024)

doi: 10.1038/nrc2222 64 KuhajdaFP

An important exploratory outcome measured in the initial 41-day Phase 2a study was the effect of cotadutide treatment on liver fat reduction as measured by MRI, with a 39.12% reduction was observed in the treatment group compared to 19.51% in placebo group (83)

Heart arrhytmias

Xu J, Gou L, Zhang P, Li H, Qiu S